ML
Insider buying
Mark Lappe bought $849K of Inhibrx Biosciences, Inc. (INBX) stock
Mark Lappe, Chief Executive Officer of Inhibrx Biosciences, Inc. (INBX), bought 10,040 shares of INBX stock worth $849K, per an SEC Form 4 filed Oct 14, 2026.
It was an open-market purchase.
The trade was reported on Oct 14, 2026.
- Traded
- Oct 14, 2026
- Disclosed
- Oct 14, 2026
- Filing delay
- 0 days
- Role
- Chief Executive Officer
- Source
- SEC Form 4
More INBX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.